Abstract
Prevalence of obesity and related complications such as type 2 diabetes (T2D) has increased dramatically in recent decades. Metabolic complications of obesity arise in part due to subcutaneous adipose tissue (SAT) dysfunction. However, it is currently unclear why some obese individuals develop insulin resistance and T2D and others do not. In this review, we discuss the role of the skin in regulating SAT function, and whether presence of inflammatory skin diseases such as psoriasis represent a novel risk mechanism mediating development of obesity-related complications.
Original language | English |
---|---|
Pages (from-to) | 59-64 |
Journal | Current Opinion in Pharmacology |
Volume | 37 |
Early online date | 3 Oct 2017 |
DOIs | |
Publication status | Published - Dec 2017 |